APO Research
Talk to an analyst

APO RESEARCH · REPORT

Belladonna Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Belladonna Tablets Market Analysis and Forecast 2026-2032

29 December 2025216 pages

Choose your research edition.

Industry ResearchBelladonna Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Belladonna Tablets Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Belladonna Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Belladonna Tablets Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Belladonna Tablets Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Belladonna Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Belladonna Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Belladonna Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Belladonna Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Belladonna Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Belladonna Tablets include Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd., Yangzhou Aidi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Wanbangde Pharmaceutical Group Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd., Shenyang Tonglian Pharmaceutical Co., Ltd., Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd., Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. and Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Belladonna Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Belladonna Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Belladonna Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Belladonna Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Belladonna Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Belladonna Tablets sales, projected growth trends, production technology, application and end-user industry.

Belladonna Tablets Segment by Company

Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.

Yangzhou Aidi Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Wanbangde Pharmaceutical Group Co., Ltd.

CSPC Ouyi Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.

Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.

Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.

Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.

Jilin Luwang Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Jilin Daojun Pharmaceutical Co., Ltd.

Henan Baiquan Pharmaceutical Co., Ltd.

Sinopharm Xinjiang Pharmaceutical Co., Ltd.

Guangxi Dahaiguang Pharmaceutical Co., Ltd.

Gansu Lanyao Pharmaceutical Co., Ltd.

Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.

Aimin Pharmaceutical Group Co., Ltd.

Weleda

Raritan Pharmaceuticals

Hyland's Inc

Belladonna Tablets Segment by Type

Compound Preparations

Single Preparations

Belladonna Tablets Segment by Application

Hospital

Clinic

Other

Belladonna Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Belladonna Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Belladonna Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Belladonna Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Belladonna Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Belladonna Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Belladonna Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Belladonna Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Compound Preparations Major Manufacturers Table 3. Single Preparations Major Manufacturers Table 4. Global Belladonna Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Belladonna Tablets Industry Trends Table 9. Belladonna Tablets Industry Drivers Table 10. Belladonna Tablets Industry Opportunities and Challenges Table 11. Belladonna Tablets Industry Restraints Table 12. Global Belladonna Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Belladonna Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Belladonna Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Belladonna Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Belladonna Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Belladonna Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Belladonna Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Belladonna Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Belladonna Tablets Sales Market Share by Region (2021-2026) Table 21. Global Belladonna Tablets Sales Market Share by Region (2027-2032) Table 22. Global Belladonna Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Belladonna Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Belladonna Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Belladonna Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Belladonna Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Belladonna Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Belladonna Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Belladonna Tablets Manufacturers, Product Type & Application Table 30. Global Belladonna Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Belladonna Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Belladonna Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Belladonna Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Belladonna Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Belladonna Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Belladonna Tablets Sales Market Share by Type (2021-2026) Table 42. Global Belladonna Tablets Sales Market Share by Type (2027-2032) Table 43. Global Belladonna Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Belladonna Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Belladonna Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Belladonna Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Belladonna Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Belladonna Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Belladonna Tablets Sales Market Share by Application (2021-2026) Table 54. Global Belladonna Tablets Sales Market Share by Application (2027-2032) Table 55. Global Belladonna Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Belladonna Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information Table 58. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview Table 59. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio Table 61. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Development Table 62. Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information Table 63. Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview Table 64. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 66. Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Development Table 67. Southwest Pharmaceutical Co., Ltd. Company Information Table 68. Southwest Pharmaceutical Co., Ltd. Business Overview Table 69. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 71. Southwest Pharmaceutical Co., Ltd. Recent Development Table 72. Wanbangde Pharmaceutical Group Co., Ltd. Company Information Table 73. Wanbangde Pharmaceutical Group Co., Ltd. Business Overview Table 74. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 76. Wanbangde Pharmaceutical Group Co., Ltd. Recent Development Table 77. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information Table 78. CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview Table 79. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 81. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development Table 82. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 83. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 84. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 86. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 87. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information Table 88. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview Table 89. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 91. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Development Table 92. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information Table 93. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview Table 94. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 96. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Development Table 97. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information Table 98. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview Table 99. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 101. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Development Table 102. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information Table 103. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview Table 104. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio Table 106. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Development Table 107. Jilin Luwang Pharmaceutical Co., Ltd. Company Information Table 108. Jilin Luwang Pharmaceutical Co., Ltd. Business Overview Table 109. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 111. Jilin Luwang Pharmaceutical Co., Ltd. Recent Development Table 112. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 113. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 114. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 116. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 117. Jilin Daojun Pharmaceutical Co., Ltd. Company Information Table 118. Jilin Daojun Pharmaceutical Co., Ltd. Business Overview Table 119. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 121. Jilin Daojun Pharmaceutical Co., Ltd. Recent Development Table 122. Henan Baiquan Pharmaceutical Co., Ltd. Company Information Table 123. Henan Baiquan Pharmaceutical Co., Ltd. Business Overview Table 124. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 126. Henan Baiquan Pharmaceutical Co., Ltd. Recent Development Table 127. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information Table 128. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview Table 129. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 131. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Development Table 132. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information Table 133. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview Table 134. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 136. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Development Table 137. Gansu Lanyao Pharmaceutical Co., Ltd. Company Information Table 138. Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview Table 139. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 141. Gansu Lanyao Pharmaceutical Co., Ltd. Recent Development Table 142. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information Table 143. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 144. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 146. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 147. Aimin Pharmaceutical Group Co., Ltd. Company Information Table 148. Aimin Pharmaceutical Group Co., Ltd. Business Overview Table 149. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 151. Aimin Pharmaceutical Group Co., Ltd. Recent Development Table 152. Weleda Company Information Table 153. Weleda Business Overview Table 154. Weleda Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Weleda Belladonna Tablets Product Portfolio Table 156. Weleda Recent Development Table 157. Raritan Pharmaceuticals Company Information Table 158. Raritan Pharmaceuticals Business Overview Table 159. Raritan Pharmaceuticals Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Raritan Pharmaceuticals Belladonna Tablets Product Portfolio Table 161. Raritan Pharmaceuticals Recent Development Table 162. Hyland's Inc Company Information Table 163. Hyland's Inc Business Overview Table 164. Hyland's Inc Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Hyland's Inc Belladonna Tablets Product Portfolio Table 166. Hyland's Inc Recent Development Table 167. North America Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 168. North America Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 169. North America Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 170. North America Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 171. North America Belladonna Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 172. North America Belladonna Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 173. North America Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 174. North America Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 175. North America Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 176. North America Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 177. North America Belladonna Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 178. North America Belladonna Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 179. North America Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. North America Belladonna Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. North America Belladonna Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. North America Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. North America Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 184. North America Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 185. North America Belladonna Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 186. North America Belladonna Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 187. United States Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 188. Canada Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 189. Mexico Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 190. Europe Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 191. Europe Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 192. Europe Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 193. Europe Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 194. Europe Belladonna Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 195. Europe Belladonna Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 196. Europe Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 197. Europe Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 198. Europe Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 199. Europe Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 200. Europe Belladonna Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 201. Europe Belladonna Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Europe Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Europe Belladonna Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Europe Belladonna Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Europe Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. Europe Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 207. Europe Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 208. Europe Belladonna Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 209. Europe Belladonna Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Germany Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 211. France Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 212. U.K. Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 213. Italy Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 214. Russia Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 215. Spain Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 216. Netherlands Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 217. Switzerland Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 218. Sweden Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 219. Poland Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 220. China Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 221. China Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 222. China Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 223. China Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 224. China Belladonna Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 225. China Belladonna Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 226. China Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 227. China Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 228. China Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 229. China Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 230. China Belladonna Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 231. China Belladonna Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 232. Asia Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 233. Asia Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 234. Asia Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 235. Asia Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 236. Asia Belladonna Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 237. Asia Belladonna Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 238. Asia Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 239. Asia Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 240. Asia Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 241. Asia Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 242. Asia Belladonna Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 243. Asia Belladonna Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 244. Asia Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. Asia Belladonna Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. Asia Belladonna Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. Asia Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. Asia Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 249. Asia Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 250. Asia Belladonna Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 251. Asia Belladonna Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Japan Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 253. South Korea Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 254. India Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 255. Australia Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 256. Taiwan Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 257. Southeast Asia Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 258. SAMEA Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 259. SAMEA Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 260. SAMEA Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 261. SAMEA Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 262. SAMEA Belladonna Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 263. SAMEA Belladonna Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 264. SAMEA Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 265. SAMEA Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 266. SAMEA Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 267. SAMEA Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 268. SAMEA Belladonna Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 269. SAMEA Belladonna Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 270. SAMEA Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 271. SAMEA Belladonna Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 272. SAMEA Belladonna Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 273. SAMEA Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 274. SAMEA Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 275. SAMEA Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 276. SAMEA Belladonna Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 277. SAMEA Belladonna Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 278. Brazil Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 279. Argentina Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 280. Chile Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 281. Colombia Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 282. Peru Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 283. Saudi Arabia Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 284. Israel Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 285. UAE Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 286. Turkey Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 287. Iran Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 288. Egypt Belladonna Tablets Revenue (2021-2032) & (US$ Million) Table 289. Key Raw Materials Table 290. Raw Materials Key Suppliers Table 291. Belladonna Tablets Distributors List Table 292. Belladonna Tablets Customers List Table 293. Research Programs/Design for This Report Table 294. Authors List of This Report Table 295. Secondary Sources Table 296. Primary Sources List of Figures Figure 1. Belladonna Tablets Image Figure 2. Global Belladonna Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Belladonna Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Compound Preparations Image Figure 5. Single Preparations Image Figure 6. Global Belladonna Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Belladonna Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Belladonna Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Belladonna Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Belladonna Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Belladonna Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Belladonna Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Belladonna Tablets Sales (2021-2032) & (K Units) Figure 17. Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Belladonna Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Belladonna Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Belladonna Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Belladonna Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Belladonna Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Belladonna Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Belladonna Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Belladonna Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Belladonna Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Belladonna Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Belladonna Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Belladonna Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Belladonna Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Belladonna Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Belladonna Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Belladonna Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Belladonna Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Belladonna Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Belladonna Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Belladonna Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Belladonna Tablets Revenue Share by Type (2021-2032) Figure 40. North America Belladonna Tablets Sales Share by Type (2021-2032) Figure 41. North America Belladonna Tablets Revenue Share by Application (2021-2032) Figure 42. North America Belladonna Tablets Sales Share by Application (2021-2032) Figure 43. North America Belladonna Tablets Revenue Share by Country (2021-2032) Figure 44. North America Belladonna Tablets Sales Share by Country (2021-2032) Figure 45. Europe Belladonna Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Belladonna Tablets Sales Share by Type (2021-2032) Figure 47. Europe Belladonna Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Belladonna Tablets Sales Share by Application (2021-2032) Figure 49. Europe Belladonna Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Belladonna Tablets Sales Share by Country (2021-2032) Figure 51. China Belladonna Tablets Revenue Share by Type (2021-2032) Figure 52. China Belladonna Tablets Sales Share by Type (2021-2032) Figure 53. China Belladonna Tablets Revenue Share by Application (2021-2032) Figure 54. China Belladonna Tablets Sales Share by Application (2021-2032) Figure 55. Asia Belladonna Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Belladonna Tablets Sales Share by Type (2021-2032) Figure 57. Asia Belladonna Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Belladonna Tablets Sales Share by Application (2021-2032) Figure 59. Asia Belladonna Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Belladonna Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Belladonna Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Belladonna Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Belladonna Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Belladonna Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Belladonna Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Belladonna Tablets Sales Share by Country (2021-2032) Figure 67. Belladonna Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Belladonna Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Compound Preparations
  • Single Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  • Yangzhou Aidi Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Wanbangde Pharmaceutical Group Co., Ltd.
  • CSPC Ouyi Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  • Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  • Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  • Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  • Jilin Luwang Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • Jilin Daojun Pharmaceutical Co., Ltd.
  • Henan Baiquan Pharmaceutical Co., Ltd.
  • Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  • Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  • Gansu Lanyao Pharmaceutical Co., Ltd.
  • Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  • Aimin Pharmaceutical Group Co., Ltd.
  • Weleda
  • Raritan Pharmaceuticals
  • Hyland's Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Belladonna Tablets Market by Type
  3. 1.2.1 Global Belladonna Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Compound Preparations
  5. 1.2.3 Single Preparations
  6. 1.3 Belladonna Tablets Market by Application
  7. 1.3.1 Global Belladonna Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Belladonna Tablets Market Dynamics
  1. 2.1 Belladonna Tablets Industry Trends
  2. 2.2 Belladonna Tablets Industry Drivers
  3. 2.3 Belladonna Tablets Industry Opportunities and Challenges
  4. 2.4 Belladonna Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Belladonna Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Belladonna Tablets Revenue by Region
  3. 3.2.1 Global Belladonna Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Belladonna Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Belladonna Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Belladonna Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Belladonna Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Belladonna Tablets Sales by Region
  9. 3.4.1 Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Belladonna Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Belladonna Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Belladonna Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Belladonna Tablets Revenue by Manufacturers
  2. 4.1.1 Global Belladonna Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Belladonna Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Belladonna Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Belladonna Tablets Sales by Manufacturers
  6. 4.2.1 Global Belladonna Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Belladonna Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Belladonna Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Belladonna Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Belladonna Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Belladonna Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Belladonna Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Belladonna Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Belladonna Tablets Market CR5 and HHI
  16. 4.8.2 2025 Belladonna Tablets Tier 1, Tier 2, and Tier 3
5 Belladonna Tablets Market by Type
  1. 5.1 Global Belladonna Tablets Revenue by Type
  2. 5.1.1 Global Belladonna Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Belladonna Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Belladonna Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Belladonna Tablets Sales by Type
  6. 5.2.1 Global Belladonna Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Belladonna Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Belladonna Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Belladonna Tablets Price by Type
6 Belladonna Tablets Market by Application
  1. 6.1 Global Belladonna Tablets Revenue by Application
  2. 6.1.1 Global Belladonna Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Belladonna Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Belladonna Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Belladonna Tablets Sales by Application
  6. 6.2.1 Global Belladonna Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Belladonna Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Belladonna Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Belladonna Tablets Price by Application
7 Company Profiles
  1. 7.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  2. 7.1.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information
  3. 7.1.2 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview
  4. 7.1.3 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio
  6. 7.1.5 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Developments
  7. 7.2 Yangzhou Aidi Pharmaceutical Co., Ltd.
  8. 7.2.1 Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  12. 7.2.5 Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Southwest Pharmaceutical Co., Ltd.
  14. 7.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  18. 7.3.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Wanbangde Pharmaceutical Group Co., Ltd.
  20. 7.4.1 Wanbangde Pharmaceutical Group Co., Ltd. Company Information
  21. 7.4.2 Wanbangde Pharmaceutical Group Co., Ltd. Business Overview
  22. 7.4.3 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  24. 7.4.5 Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments
  25. 7.5 CSPC Ouyi Pharmaceutical Co., Ltd.
  26. 7.5.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  30. 7.5.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Shenyang Tonglian Pharmaceutical Co., Ltd.
  32. 7.6.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  36. 7.6.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  38. 7.7.1 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  42. 7.7.5 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  44. 7.8.1 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  48. 7.8.5 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  50. 7.9.1 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  54. 7.9.5 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  56. 7.10.1 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information
  57. 7.10.2 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview
  58. 7.10.3 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio
  60. 7.10.5 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 7.11 Jilin Luwang Pharmaceutical Co., Ltd.
  62. 7.11.1 Jilin Luwang Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  66. 7.11.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Jilin Hengjin Pharmaceutical Co., Ltd.
  68. 7.12.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  72. 7.12.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Jilin Daojun Pharmaceutical Co., Ltd.
  74. 7.13.1 Jilin Daojun Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Jilin Daojun Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  78. 7.13.5 Jilin Daojun Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Henan Baiquan Pharmaceutical Co., Ltd.
  80. 7.14.1 Henan Baiquan Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Henan Baiquan Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  84. 7.14.5 Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  86. 7.15.1 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  90. 7.15.5 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  92. 7.16.1 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
  93. 7.16.2 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview
  94. 7.16.3 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  96. 7.16.5 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments
  97. 7.17 Gansu Lanyao Pharmaceutical Co., Ltd.
  98. 7.17.1 Gansu Lanyao Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  102. 7.17.5 Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments
  103. 7.18 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  104. 7.18.1 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information
  105. 7.18.2 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview
  106. 7.18.3 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  108. 7.18.5 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  109. 7.19 Aimin Pharmaceutical Group Co., Ltd.
  110. 7.19.1 Aimin Pharmaceutical Group Co., Ltd. Company Information
  111. 7.19.2 Aimin Pharmaceutical Group Co., Ltd. Business Overview
  112. 7.19.3 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  114. 7.19.5 Aimin Pharmaceutical Group Co., Ltd. Recent Developments
  115. 7.20 Weleda
  116. 7.20.1 Weleda Company Information
  117. 7.20.2 Weleda Business Overview
  118. 7.20.3 Weleda Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Weleda Belladonna Tablets Product Portfolio
  120. 7.20.5 Weleda Recent Developments
  121. 7.21 Raritan Pharmaceuticals
  122. 7.21.1 Raritan Pharmaceuticals Company Information
  123. 7.21.2 Raritan Pharmaceuticals Business Overview
  124. 7.21.3 Raritan Pharmaceuticals Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Raritan Pharmaceuticals Belladonna Tablets Product Portfolio
  126. 7.21.5 Raritan Pharmaceuticals Recent Developments
  127. 7.22 Hyland's Inc
  128. 7.22.1 Hyland's Inc Company Information
  129. 7.22.2 Hyland's Inc Business Overview
  130. 7.22.3 Hyland's Inc Belladonna Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Hyland's Inc Belladonna Tablets Product Portfolio
  132. 7.22.5 Hyland's Inc Recent Developments
8 North America
  1. 8.1 North America Belladonna Tablets Market Size by Type
  2. 8.1.1 North America Belladonna Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Belladonna Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Belladonna Tablets Price by Type (2021-2032)
  5. 8.2 North America Belladonna Tablets Market Size by Application
  6. 8.2.1 North America Belladonna Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Belladonna Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Belladonna Tablets Price by Application (2021-2032)
  9. 8.3 North America Belladonna Tablets Market Size by Country
  10. 8.3.1 North America Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Belladonna Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Belladonna Tablets Market Size by Type
  2. 9.1.1 Europe Belladonna Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Belladonna Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Belladonna Tablets Price by Type (2021-2032)
  5. 9.2 Europe Belladonna Tablets Market Size by Application
  6. 9.2.1 Europe Belladonna Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Belladonna Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Belladonna Tablets Price by Application (2021-2032)
  9. 9.3 Europe Belladonna Tablets Market Size by Country
  10. 9.3.1 Europe Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Belladonna Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Belladonna Tablets Market Size by Type
  2. 10.1.1 China Belladonna Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Belladonna Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Belladonna Tablets Price by Type (2021-2032)
  5. 10.2 China Belladonna Tablets Market Size by Application
  6. 10.2.1 China Belladonna Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Belladonna Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Belladonna Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Belladonna Tablets Market Size by Type
  2. 11.1.1 Asia Belladonna Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Belladonna Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Belladonna Tablets Price by Type (2021-2032)
  5. 11.2 Asia Belladonna Tablets Market Size by Application
  6. 11.2.1 Asia Belladonna Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Belladonna Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Belladonna Tablets Price by Application (2021-2032)
  9. 11.3 Asia Belladonna Tablets Market Size by Country
  10. 11.3.1 Asia Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Belladonna Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Belladonna Tablets Market Size by Type
  2. 12.1.1 SAMEA Belladonna Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Belladonna Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Belladonna Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Belladonna Tablets Market Size by Application
  6. 12.2.1 SAMEA Belladonna Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Belladonna Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Belladonna Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Belladonna Tablets Market Size by Country
  10. 12.3.1 SAMEA Belladonna Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Belladonna Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Belladonna Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Belladonna Tablets Value Chain Analysis
  2. 13.1.1 Belladonna Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Belladonna Tablets Production Mode & Process
  6. 13.2 Belladonna Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Belladonna Tablets Distributors
  9. 13.2.3 Belladonna Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst